ARROWHEAD PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 149.86K shares, a 313.76% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 130.32K shares, a 63.06% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 296.68K shares, a 326.84% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 76.59K shares, a 167.73% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 535.14K shares, a 136.78% increase from fiscal 2024.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 226.00K shares, a 48.56% decline from fiscal 2023.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 439.35K shares, a 27.53% decline from fiscal 2022.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 606.22K shares, a 42.34% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 149.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-04 | 653.45K shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 130.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | 539.81K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 296.68K shares 10-Q · filed 2026-02-05 | 762.32K shares derived: sum of 4 quarters · filed 2026-02-05 |
| 2025-09-30 | 76.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | 535.14K shares 10-K · filed 2025-11-25 |
| 2025-06-30 | 36.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07 | 487.16K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 352.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-12 | 493.99K shares derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | 69.51K shares 10-Q · filed 2025-02-10 | 261.69K shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2024-09-30 | 28.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | 226.00K shares 10-K · filed 2024-11-26 |
| 2024-06-30 | 43.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | 292.95K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 120.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | 448.06K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 33.83K shares 10-Q · filed 2024-02-06 | 391.44K shares derived: sum of 4 quarters · filed 2024-02-06 |
| 2023-09-30 | 95.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | 439.35K shares 10-K · filed 2023-11-29 |
| 2023-06-30 | 198.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-07 | 443.43K shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 63.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-02 | 307.09K shares derived: sum of 4 quarters · filed 2023-05-02 |
| 2022-12-31 | 81.73K shares 10-Q · filed 2023-02-06 | 480.14K shares derived: sum of 4 quarters · filed 2023-02-06 |
| 2022-09-30 | 99.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | 606.22K shares 10-K · filed 2022-11-28 |
| 2022-06-30 | 61.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-04 | 576.72K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 236.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10 | 676.44K shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 207.81K shares 10-Q · filed 2022-02-02 | 721.55K shares derived: sum of 4 quarters · filed 2022-02-02 |
| 2021-09-30 | 70.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-22 | 1.05M shares 10-K · filed 2021-11-22 |
| 2021-06-30 | 161.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05 | 1.10M shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 282.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-04 | 1.24M shares derived: sum of 4 quarters · filed 2021-05-04 |
| 2020-12-31 | 537.61K shares 10-Q · filed 2021-02-04 | 1.18M shares derived: sum of 4 quarters · filed 2021-02-04 |
| 2020-09-30 | 121.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-23 | 1.11M shares 10-K · filed 2020-11-23 |
| 2020-06-30 | 302.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05 | 1.29M shares derived: sum of 4 quarters · filed 2020-08-05 |
| 2020-03-31 | 214.24K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | 1.53M shares derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | 472.19K shares 10-Q · filed 2020-02-05 | 1.85M shares derived: sum of 4 quarters · filed 2020-02-05 |
| 2019-09-30 | 298.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25 | 1.54M shares 10-K · filed 2019-11-25 |
| 2019-06-30 | 541.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-05 | 1.57M shares derived: sum of 4 quarters · filed 2019-08-05 |
| 2019-03-31 | 535.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | 1.23M shares derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-12-31 | 166.33K shares 10-Q · filed 2019-02-07 | |
| 2018-09-30 | 320.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | 604.61K shares 10-K · filed 2018-12-11 |
| 2018-06-30 | 204.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-07 | |
| 2017-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12 | 135.73K shares 10-K · filed 2017-12-12 |
| 2017-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | |
| 2016-09-30 | 32.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | 37.19K shares 10-K · filed 2016-12-14 |
| 2016-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | 15.95K shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | 15.95K shares derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | 4.69K shares 10-Q · filed 2016-02-09 | 30.95K shares derived: sum of 4 quarters · filed 2016-02-09 |
| 2015-09-30 | 11.26K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | 28.76K shares 10-K · filed 2015-12-14 |
| 2015-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | 95.25K shares derived: sum of 4 quarters · filed 2015-08-04 |
| 2015-03-31 | 15.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | 130.03K shares derived: sum of 4 quarters · filed 2015-08-04 |
| 2014-12-31 | 2.50K shares 10-Q · filed 2015-02-09 | 394.54K shares derived: sum of 4 quarters · filed 2015-08-04 |
| 2014-09-30 | 77.75K shares derived: 10-Q 12 month − 10-Q 9 month · filed 2015-08-04 | 454.86K shares 10-Q · filed 2015-08-04 |
| 2014-06-30 | 34.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | 377.79K shares derived: sum of 4 quarters · filed 2014-11-25 |
| 2014-03-31 | 279.51K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-06 | 343.01K shares derived: sum of 4 quarters · filed 2014-11-25 |
| 2013-12-31 | 62.83K shares 10-Q · filed 2014-02-04 | 63.50K shares derived: sum of 4 quarters · filed 2014-11-25 |
| 2013-09-30 | 675.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | 675.00 shares 10-K · filed 2014-11-25 |
| 2013-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-07 | 9.47K shares derived: sum of 4 quarters · filed 2014-05-06 |
| 2013-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | |
| 2012-12-31 | 0.00 shares 10-Q · filed 2013-02-13 | |
| 2012-09-30 | 9.47K shares derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-06 | 4.88K shares 10-Q · filed 2014-05-06 |
| 2011-09-30 | 2.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | 2.70K shares 10-K · filed 2012-12-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |